Condition
Alveolar Echinococcosis
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07182305Phase 2CompletedPrimary
Treatment Trial of Alveolar Echinococcosis
NCT02876146Not ApplicableCompletedPrimary
Alveolar Echinococcosis: Parasite Viability and Innovative Markers for the Follow-up of Patients Treated With Albendazole
NCT00658294CompletedPrimary
Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles
NCT02509884CompletedPrimary
Long-term Results of Comprehensive AE Management
Showing all 4 trials